Geron reported $52.07M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Amgen USD 11.69B 6.9B Jun/2026
Bio Techne USD 235.92M 5.5M Mar/2026
Cassava Sciences USD 11.17M 2.38M Mar/2026
Cytokinetics USD 207.8M 7.22M Jun/2026
Exelixis USD 380.28M 20.8M Jun/2026
Genmab DKK 748M 77M Jun/2026
Geron USD 52.07M 6.73M Mar/2026
Gilead Sciences USD 3.95B 19.57B Jun/2026
Incyte USD 973.64M 4.65B Jun/2026
MacroGenics USD 42.87M 21.68M Jun/2026
Novartis USD 10.2B 912M Jun/2026
Novavax USD 126.2M 23.62M Dec/2025